Duh MS - Search Results

1

Real-world healthcare resource utilization of Alzheimer's disease in the early and advanced stages: A retrospective cohort study.

Fazio-Eynullayeva E, Cunnington M, Mystkowski P, Lv L, Aly A, Yee CW, Desai R, Liu CL, Duh MS, Mattke S. Fazio-Eynullayeva E, et al. Among authors: duh ms. J Med Econ. 2024 Dec 13:1-14. doi: 10.1080/13696998.2024.2442240. Online ahead of print. J Med Econ. 2024. PMID: 39668705 Free article.

2

Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19: Evidence from the US National COVID Cohort Collaborative (N3C).

Bell CF, Bobbili P, Desai R, Gibbons DC, Drysdale M, DerSarkissian M, Patel V, Birch HJ, Lloyd EJ, Zhang A, Duh MS; N3C consortium. Bell CF, et al. Among authors: duh ms. Clin Drug Investig. 2024 Mar;44(3):183-198. doi: 10.1007/s40261-024-01344-4. Epub 2024 Feb 20. Clin Drug Investig. 2024. PMID: 38379107 Free PMC article.

3

Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population.

Priest J, Bhak RH, Dersarkissian M, Oglesby A, Kunzweiler C, Fuqua E, Park S, Duh MS, Garris C. Priest J, et al. Among authors: duh ms. J Med Econ. 2021 Jan-Dec;24(1):1204-1211. doi: 10.1080/13696998.2021.1995868. J Med Econ. 2021. PMID: 34665994 Free article.

4

Impact of increasing adherence to disease-modifying therapies on healthcare resource utilization and direct medical and indirect work loss costs for patients with multiple sclerosis.

Yermakov S, Davis M, Calnan M, Fay M, Cox-Buckley B, Sarda S, Duh MS, Iyer R. Yermakov S, et al. Among authors: duh ms. J Med Econ. 2015;18(9):711-20. doi: 10.3111/13696998.2015.1044276. Epub 2015 Jun 1. J Med Econ. 2015. PMID: 25903661 Free article.

5

Comparative effectiveness of pegcetacoplan versus ravulizumab in patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a matching-adjusted indirect comparison.

Bhak RH, Mody-Patel N, Baver SB, Kunzweiler C, Yee CW, Sundaresan S, Swartz N, Duh MS, Krishnan S, Sarda SP. Bhak RH, et al. Among authors: duh ms. Curr Med Res Opin. 2021 Nov;37(11):1913-1923. doi: 10.1080/03007995.2021.1971182. Epub 2021 Sep 3. Curr Med Res Opin. 2021. PMID: 34445916

6

Adherence to iron chelation therapy and associated healthcare resource utilization and costs in Medicaid patients with sickle cell disease and thalassemia.

Vekeman F, Sasane M, Cheng WY, Ramanakumar AV, Fortier J, Qiu Y, Duh MS, Paley C, Adams-Graves P. Vekeman F, et al. Among authors: duh ms. J Med Econ. 2016;19(3):292-303. doi: 10.3111/13696998.2015.1117979. Epub 2015 Nov 30. J Med Econ. 2016. PMID: 26618853 Free article.

7

Treatment patterns, healthcare resource utilization, and costs of patients diagnosed with primary mediastinal B-cell lymphoma in the United States.

Yang X, Laliberté F, Germain G, Raut M, Duh MS, Sen SS, Lejeune D, Desai K, Armand P. Yang X, et al. Among authors: duh ms. J Med Econ. 2021 Jan-Dec;24(1):469-478. doi: 10.1080/13696998.2021.1908001. J Med Econ. 2021. PMID: 33784916 Free article.

8

Free combination of dutasteride plus tamsulosin for the treatment of benign prostatic hyperplasia in South Korea: analysis of drug utilization and adverse events using the National Health Insurance Review and Assessment Service database.

Lulic Z, Son H, Yoo SB, Cunnington M, Kapse P, Miller D, Cortes V, Park S, Bhak RH, Duh MS. Lulic Z, et al. Among authors: duh ms. BMC Urol. 2021 Dec 21;21(1):178. doi: 10.1186/s12894-021-00941-1. BMC Urol. 2021. PMID: 34933674 Free PMC article.

9

Evaluation of treatment patterns, healthcare resource utilization, and costs among patients receiving treatment for cytomegalovirus following allogeneic hematopoietic cell or solid organ transplantation.

Cheng WY, Avery RK, Thompson-Leduc P, Cheung HC, Bo T, Duh MS, Hirji I. Cheng WY, et al. Among authors: duh ms. J Med Econ. 2022 Jan-Dec;25(1):367-380. doi: 10.1080/13696998.2022.2046388. J Med Econ. 2022. PMID: 35240904 Free article.

10

Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study.

Wang PF, Yee CW, Gorsh B, Zichlin ML, Paka P, Bhak RH, Boytsov N, Khanal A, Noman A, DerSarkissian M, Ferrante S, Duh MS. Wang PF, et al. Among authors: duh ms. Leuk Lymphoma. 2023 Feb;64(2):398-406. doi: 10.1080/10428194.2022.2140284. Epub 2022 Nov 21. Leuk Lymphoma. 2023. PMID: 36408998

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

325 results

Search Page

Filters